These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 18665745)

  • 1. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
    Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
    Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer: stem cells and brain tumours.
    Dirks PB
    Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
    [No Abstract]   [Full Text] [Related]  

  • 4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
    Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
    Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting brain-tumor stem cells.
    Stupp R; Hegi ME
    Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma cancer stem cells--from concept to clinical application.
    Stopschinski BE; Beier CP; Beier D
    Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
    Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
    Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of DNA repair in stem and nonstem glioma cell cultures.
    Ropolo M; Daga A; Griffero F; Foresta M; Casartelli G; Zunino A; Poggi A; Cappelli E; Zona G; Spaziante R; Corte G; Frosina G
    Mol Cancer Res; 2009 Mar; 7(3):383-92. PubMed ID: 19276180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
    Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
    Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
    Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
    Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.